Further biochemical characterizations are required to determine whether ALKBH6 repairs m1A or m3C. Our data provide a basis for future studies to uncover the clinical benefit of ALKBH6 in certain cancers as a prognostic marker or a potential target for therapy. This evidence concerns the gene ALKBH6 and cancer.